Basic Information

Symbol
circGCN1L1
RNA Class
circRNA
Alias
GCN1 Activator Of EIF2AK4 KIAA0219 GCN1L1 GCN1L GCN1 (General Control Of Amino-Acid Synthesis 1, Yeast)-Like 1 General Control Of Amino-Acid Synthesis 1-Like Protein 1 GCN1, EIF2 Alpha Kinase Activator Homolog GCN1 EIF-2-Alpha Kinase Activator Homolog Stalled Ribosome Sensor GCN1 Translational Activator GCN1 GCN1-Like Protein 1 HsGCN1 Peroxisome Proliferator Activated Receptor Interacting Complex Protein GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 (Yeast) GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 EIF-2-Alpha Kinase Activator GCN1 PRIC295
Location (GRCh37)
12:120567080-120632513 UCSC Genome Browser
Location (GRCh38)
Host gene
GCN1L1
Host category
mRNA
Forensic tag(s)
Other applications
External database

Transcripts

ID Type Location (GRCh37) Location (GRCh38) Length GC content
hsa_GCN1L1_0006500 Exon-Exon chr12:120582110-120585076 chr12:120144306-120147272 769 nt 0.5696
hsa_GCN1L1_0006600 Exon-Exon chr12:120582110-120593523 chr12:120144306-120155719 2183 nt 0.5735
hsa_GCN1L1_0006800 Exon-Exon chr12:120583066-120594408 chr12:120145262-120156604 1848 nt 0.5812
hsa_GCN1L1_0006900 Exon-Exon chr12:120583066-120597827 chr12:120145262-120160023 2466 nt 0.5908
hsa_GCN1L1_0007000 Exon-Exon chr12:120583066-120599387 chr12:120145262-120161583 2674 nt 0.5868
hsa_GCN1L1_0007100 Exon-Exon chr12:120583066-120599862 chr12:120145262-120162058 2853 nt 0.5875
hsa_GCN1L1_0007200 Exon-Exon chr12:120583066-120601063 chr12:120145262-120163259 250 nt 0.4800
hsa_GCN1L1_0007300 Exon-Exon chr12:120583066-120608125 chr12:120145262-120170321 250 nt 0.4680
hsa_GCN1L1_0007400 Exon-Exon chr12:120583066-120611630 chr12:120145262-120173826 250 nt 0.4280
hsa_GCN1L1_0007500 Exon-Exon chr12:120583066-120615358 chr12:120145262-120177555 250 nt 0.4360
Showing 51 to 60 of 152 entries
Forensic Context

A review consolidating existing research indicates that in various mammalian species, the circGCN1L1 serves as an example where its expression was experimentally abolished using CRISPR/Cas9 genome-editing without affecting the expression of its corresponding linear mRNA [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].